Research Associate Professor
Research Scientist
Psychology
Public Health
Jacobs School of Medicine and Biomedical Sciences
University at Buffalo, State University of New York
UB Downtown Gateway
77 Goodell St.
Suite 420
Buffalo, NY 14203
Medical Cannabis; novel and emerging cannabinoids; therapeutic use of psychedelics; integration of Cannabis and psychedelics with healthcare and health professions education
Kruger, D.J., Barron, J., Herberholz, M., & Boehnke, K.F. (2023). Preferences and support for psychedelic policies and practices among those using psychedelics. Journal of Psychoactive Drugs. https://doi.org/10.1080/02791072.2023.2228784
Kruger, D.J., Bone, C.B., Meacham, M.C., Klein, C., & Kruger, J. S. (2023). THC-O-acetate: Scarce evidence for a psychedelic cannabinoid. Journal of Psychoactive Drugs. https://doi.org/10.1080/02791072.2023.2230573
Bone, C.B., Klein, C., Munger, K., Strongin, R.M., Kruger, D.J., Meacham, M.C., & Kruger, J. S. (2023). Reviewing the risk of ketene formation in dabbing and vaping THC-O-acetate. Cannabis and Cannabinoid Research. https://doi.org/10.1089/can.2023.0094
Kruger, D.J., Gerlach, J., Kruger, J.S., Mokbel, M.M., Clauw, D.J., & Boehnke, K.F. (2023). Physicians’ attitudes and practices regarding Cannabis and recommending medical Cannabis use. Cannabis and Cannabinoid Research. https://doi.org/10.1089/can.2022.0324
Kruger, D.J., Enghoff, O., Herberholz, M., Barron, J., & Boehnke, K.F. (2023). “How do I learn more about this?”: Utilization and trust of psychedelic information sources among people naturalistically using psychedelics. Journal of Psychoactive Drugs. https://doi.org/10.1080/02791072.2023.2201263
Kruger, D.J. & Kruger, J.S. (2023). Consumer experiences with delta-8-THC: Medical use, pharmaceutical substitution, and comparisons with delta-9-THC. Cannabis and Cannabinoid Research, 8, 166-173. https://doi.org/10.1089/can.2021.0124
Kruger, D.J., Karahmet, A., Kaplan, S.M., Redfield, J., Stacy, T., Agarwal, V., Faqqouseh, M., & Bone, C.B. (2023). Social media discussions on THC-O-acetate: A content analysis. Cannabis, 6 (2). https://doi.org/10.26828/cannabis/2023/000164
Kruger, D.J., Glynos, N.G., Fields, C.W., Herberholz, M., & Boehnke, K.F. (2023). An assessment of psychedelic knowledge among people using psychedelics naturalistically. Journal of Psychoactive Drugs, 55, 420-424. https://doi.org/10.1080/02791072.2022.2142709
Allard, N.C., Kruger, J.S., & Kruger, D.J. (2023). Cannabis advertising policies in the United States: State-level variation and comparison with Canada. Cannabis and Cannabinoid Research, 8, 505-509. https://doi.org/10.1089/can.2022.0068
Holman, A., Kruger, D.J., Lucas, P., Ong, K., Bergmans, R.S., Boehnke, K.F. (2023). Healthcare provider and medical cannabis patient communication regarding referral and medication substitution: The Canadian context. Journal of Cannabis Research, 4, 32. https://doi.org/10.1186/s42238-022-00141-0
Kruger, J.S., & Kruger, D.J. (2022). Delta-8-THC: Delta-9-THC’s nicer younger sibling? Journal of Cannabis Research, 4, 4. https://doi.org/10.1186/s42238-021-00115-8
Kruger, D.J., Mokbel, M.M., Clauw, D.J., & Boehnke, K.F. (2022). Assessing healthcare providers’ knowledge of medical Cannabis. Cannabis and Cannabinoid Research, 7, 501-507. https://doi.org/10.1089/can.2021.0032